The principles of guided tissue and bone regeneration are covered in detail, including many recent advancements in barrier membrane technologies as well as use of platelet-rich fibrin and various growth factors, and many next-generation materials that will optimize future bone and periodontal regeneration are presented. The final section of the course is designed to help clinicians select appropriate biomaterials for each specific regenerative protocol. Much like one implant size and shape cannot be utilized for every indication in implant dentistry, one bone grafting material, barrier membrane, or growth factor cannot maximize regenerative outcomes in all clinical situations. This course teaches clinicians how to utilize biomaterials in an appropriate, predictable, and evidence-based manner.

More information: ICI

AUTRES CONFÉRENCIERS:

Nancy Tawil, PhD
Vice President Research
Phagelux Inc.
Associate Professor, Ecole Polytechnique de Montreal

Bacteriophages for the Prevention and Treatment of Implant Associated Multi-Drug-Resistant Infections and Biofilms

The emergence of antibiotic resistance is one of the greatest threats we face today. The increase in opportunistic ESKAPE pathogens has proven extremely difficult to control, and there has been little in advances in conventional therapies to their prevention or treatment. The US Centers for Disease Control and Prevention estimates that each year more than 2 million patients are infected with antibiotic-resistant bacteria, and at least 23,000 people die from resistant infections.The increased rate of multi-drug resistance of these infections pose a significant challenge to appropriate treatment pathways. In order to address this challenge, it is important to consider novel approaches to treating and preventing multi-drug resistant infections.Antibacterial products utilizing bacteriophages, endolysins and other biological solutions offer the possibility to target antibiotic resistant bacteria (AMR). Phages have many characteristics that make them a strong solution as apreventative, treatment or adjunct therapy. In response to the growing global crisis of antimicrobial resistance, PhageluxInc. has developed a cocktail of lytic phages that respond to a broad array of pathogens and can be used as a standaloneor adjunct to antibiotics. Novelimmobilization andphage delivery solutions showingpromise in the treatment of implant associated infectionsand post-operative fieldwill be discussed.

L'Hocine Yahia, PhD
LIAB director
Professor, Polytechnique Montreal

Nanomaterials in Dentistry

The emerging science of nanotechnology, especially within the dental and medical fields, sparked a research interest in their potential applications and benefits in comparison to conventional materials used. Nanotechnology is going to be an essential part of the clinical dental practice. Nanomaterials are used in toothpaste and other rinsing solutions for better oral healthcare services which will become less stressful for the dental surgeons. New nano strategies cope up to address the dental problems. Nanomaterials used in the dental filling, polishing of the enamel surface to prevent caries, also used as implant materials that are more effective than the conventional materials. Some of the nanoparticles act as antimicrobial agent thus prevent bacterial growth. Nanodentistry attracts patients towards dentistry, since, it will be cost effective, time-saving and prevent the patient from mental trauma. Development of modified nanomaterials is surely going to help to solve the dental problems. Nanotechnology’s effect for treatment of oral disease is limited, which rapidly progress the investigations ensuring developments that are possible in near future. Additionally, nano-applications in dental diagnostics, dental prevention, and in dental materials will be addressed, with examples of commercially available products and evidence on their clinicalperformance.